| UniProt ID | ITB2_MOUSE | |
|---|---|---|
| UniProt AC | P11835 | |
| Protein Name | Integrin beta-2 | |
| Gene Name | Itgb2 | |
| Organism | Mus musculus (Mouse). | |
| Sequence Length | 771 | |
| Subcellular Localization |
Cell membrane Single-pass type I membrane protein . Membrane raft Single-pass type I membrane protein . |
|
| Protein Description | Integrin ITGAL/ITGB2 is a receptor for ICAM1, ICAM2, ICAM3 and ICAM4. Integrins ITGAM/ITGB2 and ITGAX/ITGB2 are receptors for the iC3b fragment of the third complement component and for fibrinogen. Integrin ITGAX/ITGB2 recognizes the sequence G-P-R in fibrinogen alpha-chain. Integrin ITGAM/ITGB2 recognizes P1 and P2 peptides of fibrinogen gamma chain. Integrin ITGAM/ITGB2 is also a receptor for factor X. Integrin ITGAD/ITGB2 is a receptor for ICAM3 and VCAM1. Contributes to natural killer cell cytotoxicity (By similarity). Involved in leukocyte adhesion and transmigration of leukocytes including T-cells and neutrophils (By similarity). Triggers neutrophil transmigration during lung injury through PTK2B/PYK2-mediated activation. [PubMed: 18587400 Integrin ITGAL/ITGB2 in association with ICAM3, contributes to apoptotic neutrophil phagocytosis by macrophages (By similarity In association with alpha subunit ITGAM/CD11b, required for CD177-PRTN3-mediated activation of TNF primed neutrophils (By similarity Alpha-M/beta-2 play a critical role in mast cell development and in immune complex-mediated glomerulonephritis. Mice expressing a null mutation of the alpha-M subunit gene demonstrate increase in neutrophil accumulation, in response to a impaired degranulation and phagocytosis, events that apparently accelerate apoptosis in neutrophils. These mice develop obesity.] | |
| Protein Sequence | MLGLRPSLLLALAGLFFLGSAVSQECTKYKVSSCRDCIQSGPGCSWCQKLNFTGPGEPDSLRCDTRAQLLLKGCPADDIMDPRSIANPEFDQRGQRKQLSPQKVTLYLRPGQAAAFNVTFRRAKGYPIDLYYLMDLSYSMLDDLNNVKKLGGDLLQALNEITESGRIGFGSFVDKTVLPFVNTHPEKLRNPCPNKEKACQPPFAFRHVLKLTDNSNQFQTEVGKQLISGNLDAPEGGLDAIMQVAACPEEIGWRNVTRLLVFATDDGFHFAGDGKLGAILTPNDGRCHLEDNMYKRSNEFDYPSVGQLAHKLSESNIQPIFAVTKKMVKTYEKLTEIIPKSAVGELSDDSSNVVQLIKNAYYKLSSRVFLDHSTLPDTLKVTYDSFCSNGASSIGKSRGDCDGVQINNPVTFQVKVMASECIQEQSFVIRALGFTDTVTVQVRPQCECQCRDQSREQSLCGGKGVMECGICRCESGYIGKNCECQTQGRSSQELERNCRKDNSSIVCSGLGDCICGQCVCHTSDVPNKEIFGQYCECDNVNCERYNSQVCGGSDRGSCNCGKCSCKPGYEGSACQCQRSTTGCLNARLVECSGRGHCQCNRCICDEGYQPPMCEDCPSCGSHCRDNHTSCAECLKFDKGPFEKNCSVQCAGMTLQTIPLKKKPCKERDSEGCWITYTLQQKDGRNIYNIHVEDSLECVKGPNVAAIVGGTVVGVVLIGVLLLVIWKALTHLTDLREYRRFEKEKLKSQWNNDNPLFKSATTTVMNPKFAES | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 24 | Pyrrolidone_carboxylic_acid | FLGSAVSQECTKYKV HHHHHHCHHHHCCCC | 43.09 | - | |
| 51 | N-linked_Glycosylation | CSWCQKLNFTGPGEP CCHHHHCCCCCCCCC | 39.20 | - | |
| 53 | Phosphorylation | WCQKLNFTGPGEPDS HHHHCCCCCCCCCCC | 41.20 | - | |
| 117 | N-linked_Glycosylation | PGQAAAFNVTFRRAK CCCCEEEEEEEEECC | 27.48 | - | |
| 192 | Glutathionylation | PEKLRNPCPNKEKAC HHHHCCCCCCHHHHC | 7.10 | 24333276 | |
| 247 | Glutathionylation | AIMQVAACPEEIGWR HHHHHHCCCHHHCCC | 2.92 | 24333276 | |
| 255 | N-linked_Glycosylation | PEEIGWRNVTRLLVF CHHHCCCCEEEEEEE | 32.76 | - | |
| 387 | Glutathionylation | KVTYDSFCSNGASSI EEEHHHHCCCCCHHC | 3.41 | 24333276 | |
| 421 | Glutathionylation | VKVMASECIQEQSFV EEEEHHHHHHHCCEE | 3.45 | 24333276 | |
| 502 | N-linked_Glycosylation | ERNCRKDNSSIVCSG HHHHCCCCCCEECCC | 40.46 | - | |
| 626 | N-linked_Glycosylation | CGSHCRDNHTSCAEC CCCHHCCCCCCHHHH | 22.45 | - | |
| 644 | N-linked_Glycosylation | DKGPFEKNCSVQCAG CCCCCCCCCCCEECC | 18.99 | - | |
| 672 | Glutathionylation | KERDSEGCWITYTLQ CCCCCCCCEEEEEEE | 1.77 | 24333276 | |
| 746 | Ubiquitination | RFEKEKLKSQWNNDN HHHHHHHHHHHCCCC | 52.23 | - | |
| 747 | Phosphorylation | FEKEKLKSQWNNDNP HHHHHHHHHHCCCCC | 51.36 | - | |
| 758 | Phosphorylation | NDNPLFKSATTTVMN CCCCCHHHHHEEECC | 24.42 | 21082442 | |
| 760 | Phosphorylation | NPLFKSATTTVMNPK CCCHHHHHEEECCHH | 30.05 | 19060867 | |
| 761 | Phosphorylation | PLFKSATTTVMNPKF CCHHHHHEEECCHHH | 19.67 | 29472430 | |
| 762 | Phosphorylation | LFKSATTTVMNPKFA CHHHHHEEECCHHHC | 17.25 | 29472430 | |
| 767 | Ubiquitination | TTTVMNPKFAES--- HEEECCHHHCCC--- | 52.80 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ITB2_MOUSE !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ITB2_MOUSE !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ITB2_MOUSE !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| 1433B_MOUSE | Ywhab | physical | 18239087 |
| Kegg Drug | ||||||
|---|---|---|---|---|---|---|
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...